EP09.01 intraoperative radiotherapy for resectable brain metastases: a systematic review and meta-analysis
Abstract
In recent years, intraoperative radiotherapy (IORT) with low-energy X-rays is emerging as an alternative to postoperative stereotactic radiotherapy (SRT) of the resection cavity in patients with resectable brain metastases (BMs).
We performed a systematic review of the MEDLINE, Embase, and Scopus databases, including all original articles on IORT for resectable BMs from 2015−2025. Data on safety, local control, and survival outcomes were collected.
Ten records (5 prospective single-arm trials) were included, representing 261 patients (49% lung primary) with a median follow-up (range) of 14 (0−79) months. 77% of patients had a solitary BM at the time of surgery and IORT. The median applicator size was 2.0 cm and the median prescribed dose (range) 22.3 (20−30) Gy. The 1-year local control rate was 93% and the 1-year distant brain control rate 48%. Median overall survival was 19 months. Only 6% of patients developed leptomeningeal disease and the cumulative rate of radiation necrosis was 2.6% (grade 1 in 56% of cases). The median time to next treatment (range) was 31 (1−136) days. This was significantly shorter compared to SRT control collectives.
IORT for patients with BMs has a favorable toxicity profile and yields excellent local control. A potential advantage is the rapid completion of interdisciplinary BM treatment, allowing a swift transition to subsequent cancer treatments. A planned registry and a prospective randomized phase 3 trial will establish the preferred…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 261 participants or records.
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.